(Q35239122)

7 August 2017

1 reference

title

Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy (English)

1 reference

Lambert-Eaton myasthenic syndrome

7 August 2017

main subject

1 reference

Nils Erik Gilhus

1 reference

7 August 2017

publication date

29 September 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

2011

1 reference

7 August 2017

page(s)

973808

1 reference

Creative Commons Attribution 3.0 Unported

7 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Myasthenia and related disorders of the neuromuscular junction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Guidelines for treatment of autoimmune neuromuscular transmission disorders

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Management of myasthenic conditions: nonimmune issues

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Calcium channels, neuromuscular synaptic transmission and neurological diseases.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Treatment for Lambert-Eaton myasthenic syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.

13 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Treatment for Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F973808

Regulatory T cells in paraneoplastic neurological syndromes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182560

Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS

26 September 2018

1 reference

12 December 2020

Unusual paraneoplastic syndromes of breast carcinoma: a combination of cerebellar degeneration and Lambert-Eaton Myasthenic Syndrome

1 reference

12 December 2020

Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients

1 reference

12 December 2020

Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

1 reference

12 December 2020

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor

1 reference

12 December 2020

Transient neonatal Lambert-Eaton syndrome

1 reference

12 December 2020

SOX Antibodies in Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: Frequency and Relation With Survival

1 reference

12 December 2020

Lambert-eaton myasthenic syndrome

1 reference

12 December 2020

Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse

1 reference

12 December 2020

The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/973808

1 reference

7 August 2017

1 reference

7 August 2017

1 reference